Medical Minutes

Share

Program Content

Activities

  • Adjuvant CDK Inhibitors for EBC
    Integrating Adjuvant CDK4/6 Inhibitors Into Care of Patients With HR-Positive/HER2-Negative Early-Stage Breast Cancer
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 01, 2024

    Expires: April 30, 2025

  • BRCA Testing and Targeting in EBC
    Germline BRCA Testing and Targeting in HER2-Negative Early-Stage Breast Cancer
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 07, 2024

    Expires: May 06, 2025

  • ICIs for EBC
    Immune Checkpoint Inhibitor Therapy for HER2-Negative Early-Stage Breast Cancer
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 13, 2024

    Expires: May 12, 2025

Faculty

cover img faculity

Tanya Gupta, MD

Clinical Assistant Professor
Breast Oncology
Stanford Healthcare
Palo Alto, California

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Merck Sharp & Dohme, LLC, and Novartis Pharmaceuticals Corporation.

AstraZeneca

Merck Sharp & Dohme, LLC

Novartis Pharmaceuticals Corporation

Partners

Breastcancer.org

ProCE Banner